tradingkey.logo

Caris Life Sciences Inc

CAI
16.590USD
-1.740-9.49%
交易中 美東報價延遲15分鐘
4.61B總市值
虧損本益比TTM

Caris Life Sciences Inc

16.590
-1.740-9.49%

關於 Caris Life Sciences Inc 公司

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Caris Life Sciences Inc簡介

公司代碼CAI
公司名稱Caris Life Sciences Inc
上市日期Jun 18, 2025
CEOHalbert (David Dean)
員工數量- -
證券類型Ordinary Share
年結日Jun 18
公司地址750 W. John Carpenter Freeway
城市IRVING
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編75039
電話18667718946
網址https://www.carislifesciences.com/
公司代碼CAI
上市日期Jun 18, 2025
CEOHalbert (David Dean)

Caris Life Sciences Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-2.84%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
163.54K
+39.12%
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
2.49K
-547.23%
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
Independent Director
Independent Director
--
--
Mr. Jon S. Halbert
Mr. Jon S. Halbert
Director
Director
--
--
Ms. Laura I. Johansen
Ms. Laura I. Johansen
Independent Director
Independent Director
--
--
Dr. Lloyd B. Minor, M.D.
Dr. Lloyd B. Minor, M.D.
Independent Director
Independent Director
--
--
Mr. Vijay Mohan
Mr. Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Danny Phillips
Mr. Danny Phillips
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-2.84%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
163.54K
+39.12%
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
2.49K
-547.23%
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
Independent Director
Independent Director
--
--
Mr. Jon S. Halbert
Mr. Jon S. Halbert
Director
Director
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
213.55M
98.49%
International
3.28M
1.51%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 3月20日 週五
更新時間: 3月20日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Halbert (David D)
43.56%
J.H. Whitney Capital Partners, LLC
7.17%
Sixth Street Partners, LLC
6.86%
Fidelity Management & Research Company LLC
4.48%
Castleman Peter M
3.67%
其他
34.26%
持股股東
持股股東
佔比
Halbert (David D)
43.56%
J.H. Whitney Capital Partners, LLC
7.17%
Sixth Street Partners, LLC
6.86%
Fidelity Management & Research Company LLC
4.48%
Castleman Peter M
3.67%
其他
34.26%
股東類型
持股股東
佔比
Individual Investor
48.61%
Investment Advisor
30.05%
Hedge Fund
14.08%
Private Equity
8.70%
Investment Advisor/Hedge Fund
4.87%
Research Firm
0.92%
Pension Fund
0.58%
Sovereign Wealth Fund
0.04%
Bank and Trust
0.02%

機構持股

更新時間: 1月21日 週三
更新時間: 1月21日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q4
228
134.49M
38.87%
--
2025Q4
261
137.01M
48.56%
+26.69M
2025Q3
172
130.04M
46.09%
+127.36M
2025Q2
45
192.42M
69.23%
+189.87M
2025Q1
3
2.55M
0.92%
+2.55M

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Halbert (David D)
122.76M
43.51%
-141.96K
-0.12%
Aug 11, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.18%
+20.26M
--
Jun 30, 2025
Sixth Street Partners, LLC
24.39M
8.64%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
9.58M
3.39%
+963.04K
+11.18%
Sep 30, 2025
Castleman Peter M
10.37M
3.68%
+10.34M
+32049.87%
Jun 18, 2025
Coatue Management, L.L.C.
10.14M
3.59%
--
--
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
8.03M
2.84%
+721.77K
+9.88%
Sep 30, 2025
Braidwell LP
7.32M
2.59%
--
--
Sep 30, 2025
PointState Capital LP
3.88M
1.38%
+1.39M
+55.45%
Sep 30, 2025
T. Rowe Price Associates, Inc.
6.92M
2.45%
+154.50K
+2.29%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
ARK Genomic Revolution ETF
0.67%
Texas Capital Texas Small Cap Equity Index ETF
0.52%
Renaissance IPO ETF
0.43%
RiverNorth Patriot ETF
0.3%
Franklin Genomic Advancements ETF
0.29%
Invesco Russell 1000 Equal Weight ETF
0.08%
Inspire 500 ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.05%
Texas Capital Texas Equity Index ETF
0.04%
Fidelity Nasdaq Composite Index ETF
0.02%
查看更多
ARK Genomic Revolution ETF
佔比0.67%
Texas Capital Texas Small Cap Equity Index ETF
佔比0.52%
Renaissance IPO ETF
佔比0.43%
RiverNorth Patriot ETF
佔比0.3%
Franklin Genomic Advancements ETF
佔比0.29%
Invesco Russell 1000 Equal Weight ETF
佔比0.08%
Inspire 500 ETF
佔比0.07%
T Rowe Price Small-Mid Cap ETF
佔比0.05%
Texas Capital Texas Equity Index ETF
佔比0.04%
Fidelity Nasdaq Composite Index ETF
佔比0.02%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI